2024-512151-21-00CompletedPhase 1
A Phase 1, Open-Label Study to Investigate the TARP-ɣ8 Receptor Occupancy of RAP-219 Using a TARP-γ8 PET Tracer in Healthy Adult Participants
Source: EU CTIS (euclinicaltrials.eu) · Last updated 27 May 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 12 Apr 2024
- Start date
- 19 Jun 2024
- Lead sponsor
- Rapport Therapeutics Inc.
- EU CT number
- 2024-512151-21-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 24
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UZ Leuven | Leuven | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.